Addex Therapeutics Ltd (ADXN)

Addex Therapeutics Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Addex Therapeutics stock has a target of 38.12, which predicts a 445.35% increase from the current stock price of 6.99.

Price Target: $38.12 (+445.35%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$38.12	$38.12	$38.12	$38.12
Change	+445.35%	+445.35%	+445.35%	+445.35%

Analyst Ratings

According to 1 stock analyst, the rating for Addex Therapeutics is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	May '24	Jun '24	Jul '24	Aug '24	Sep '24	Oct '24
Strong Buy	0	0	1	1	1	0
Buy	0	0	0	0	0	0
Hold	1	1	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	1	1	1	1	0

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $30	Strong Buy	Reiterates	$30	+329.18%	Oct 2, 2024
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $30	Strong Buy	Reiterates	$30	+329.18%	Aug 28, 2024
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Hold → Strong Buy Upgrades $30	Hold → Strong Buy	Upgrades	$30	+329.18%	Jul 31, 2024
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Jun 23, 2022
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $420 → $300	Strong Buy	Maintains	$420 → $300	+4,191.85%	May 31, 2022

More Analyst Ratings

Financial Forecast

Revenue This Year

765.00K

Increased by 342.20%

from 173.00K

Revenue Next Year

n/a

from 765.00K

EPS This Year

-0.04

from -0.06

EPS Next Year

n/a

from -0.04

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	3.15M	1.44M	1.62M	410.04K	173.00K	765.00K	-
Revenue Growth	-18.71%	-54.18%	11.92%	-74.65%	-57.81%	342.20%	-
EPS	-0.45	-0.46	-0.14	0.07	-0.06	-0.04	-
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	3	3

Financial currency is CHF. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	1.6M	n/a
Avg	765,000	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	810.4%	-
Avg	342.2%	-
Low	-	-

EPS Forecast

EPS	2026
High	-0.04
Avg	-0.04
Low	-0.04

EPS Growth

EPS Growth	2026
High	-
Avg	-
Low	-

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.